LA MÉPHÉDRONE: une nouvelle forme de toxicomanie = MEPAEDRONEBERTRAND, X; GENSBURGER, M; STECKX, E et al.RMLG. Revue médicale de Liège. 2011, Vol 66, Num 10, issn 0370-629X, 540-544 [5 p.]Article

A review of the neuropharmacological properties of khatFEYISSA, Anteneh M; KELLY, John P.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 5, pp 1147-1166, issn 0278-5846, 20 p.Article

Canthin-6-one alkaloids from Brucea antidysenterica root barkCANTHIN, A; ANDERSON, L. A; PHILLIPSON, J. D et al.Planta medica. 1985, Num 2, pp 151-153, issn 0032-0943Article

Analytical Toxicology of Emerging Drugs of Abuse—An UpdateMEYER, Markus R; PETERS, Frank T.Therapeutic drug monitoring. 2012, Vol 34, Num 6, pp 615-621, issn 0163-4356, 7 p.Article

Bath SaltsGERONA, Roy R; WU, Alan H. B.Clinics in laboratory medicine. 2012, Vol 32, Num 3, issn 0272-2712, vi, 415-427 [14 p.]Article

The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologsDAL CASON, T. A.Forensic science international. 1997, Vol 87, Num 1, pp 9-53, issn 0379-0738Article

Synthesis, full chemical characterisation and development of validated methods for the quantification of (±)-4-methylmethcathinone (mephedrone): A new legal highSANTALI, Eman Y; CADOGAN, Anna-Karina; NIC DAEID, Niamh et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 56, Num 2, pp 246-255, issn 0731-7085, 10 p.Article

In vivo Effects of Abused 'Bath Salt' Constituent 3,4-methylenedioxypyrovalerone (MDPV) in Mice: Drug Discrimination, Thermoregulation, and Locomotor ActivityFANTEGROSSI, William E; GANNON, Brenda M; ZIMMERMAN, Sarah M et al.Neuropsychopharmacology (New York, NY). 2013, Vol 38, Num 4, pp 563-573, issn 0893-133X, 11 p.Article

Synthesis, full chemical characterisation and development of validated methods for the quantification of the components found in the evolved legal high NRG-2KHREIT, Osama I. G; IRVING, Craig; SCHMIDT, Elke et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 61, pp 122-135, issn 0731-7085, 14 p.Article

Synthetic Cathinones (Bath Salts): Legal Status and Patterns of AbuseFASS, Jennifer A; FASS, Andrea D; GARCIA, Angela S et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 3, pp 436-441, issn 1060-0280, 6 p.Article

Synthesis and GC―MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV)HAMAD ABIEDALLA, Younis F; ABDEL-HAY, Karim; DERUITER, Jack et al.Forensic science international. 2012, Vol 223, Num 1-3, pp 189-197, issn 0379-0738, 9 p.Article

Khat Chewing from the Pharmacological Point of View : An UpdateGRAZIANI, Manuela; MILELLA, Michele S; NENCINI, Paolo et al.Substance use & misuse. 2008, Vol 43, Num 6, pp 762-783, issn 1082-6084, 22 p.Article

Effects of synthetic cathinones contained in bath salts on motor behavior and a functional observational battery in miceMARUSICH, Julie A; GRANT, Kateland R; BLOUGH, Bruce E et al.Neurotoxicology (Park Forest South). 2012, Vol 33, Num 5, pp 1305-1313, issn 0161-813X, 9 p.Article

3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed onlineCOPPOLA, M; MONDOLA, R.Toxicology letters. 2012, Vol 208, Num 1, pp 12-15, issn 0378-4274, 4 p.Article

Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as bath salts or plant foodCOPPOLA, M; MONDOLA, R.Toxicology letters. 2012, Vol 211, Num 2, pp 144-149, issn 0378-4274, 6 p.Article

Discriminative stimulus effects of S(-)-methcathinone (CAT) : a potent stimulant drug of abuseYOUNG, R; GLENNON, R. A.Psychopharmacologia. 1998, Vol 140, Num 3, pp 250-256, issn 0033-3158Article

A web-based survey on mephedroneCARHART-HARRIS, R. L; KING, L. A; NUTT, D. J et al.Drug and alcohol dependence. 2011, Vol 118, Num 1, pp 19-22, issn 0376-8716, 4 p.Article

Khat in the Horn of Africa: Historical perspectives and current trendsGEBISSA, Ezekiel.Journal of ethnopharmacology. 2010, Vol 132, Num 3, pp 607-614, issn 0378-8741, 8 p.Article

Liquid chromatographic direct resolution of aryl α-amino ketones on a residual silanol group-protecting chiral stationary phase based on optically active 3,3' -diphenyl-1,1-binaphthyl-20 -crown-6CHOI, Heejung; JONG SUNG JIN; MYUNG HO HYUN et al.Journal of chromatography. B. 2008, Vol 875, Num 1, pp 102-107, issn 1570-0232, 6 p.Article

Evidence of mephedrone chronic abuse through hair analysis using GC/MSMARTIN, M; MULLER, J. F; TURNER, K et al.Forensic science international. 2012, Vol 218, Num 1-3, pp 44-48, issn 0379-0738, 5 p.Conference Paper

Acute Coronary Syndrome and Khat Herbal Amphetamine Use: An Observational ReportALI, Waleed M; AL HABIB, K. F; AMIN, Haitham et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 24, pp 2681-2689, issn 0009-7322, 9 p.Article

Not for Human Consumption: A Review of Emerging Designer DrugsMUSSELMAN, Megan E; HAMPTON, Jeremy P.Pharmacotherapy. 2014, Vol 34, Num 7, pp 745-757, issn 0277-0008, 13 p.Article

Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and -8 in human leukaemia cellsDIMBA, E. A. O; GJERTSEN, B. T; BREDHOLT, T et al.British journal of cancer. 2004, Vol 91, Num 9, pp 1726-1734, issn 0007-0920, 9 p.Article

Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)-cathine and several structural modificationsGLENNON, R. A; SCHECHTER, M. D; ROSECRANS, J. A et al.Pharmacology, biochemistry and behavior. 1984, Vol 21, Num 1, pp 1-3, issn 0091-3057Article

A CONSTITUENT OF KHAT LEAVES WITH AMPHETAMINE-LIKE RELEASING PROPERTIESKALIX P.1980; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1980; VOL. 68; NO 2; PP. 213-215; BIBL. 10 REF.Article